4by4 Inc (KOSDAQ:389140)
14,470
-570 (-3.79%)
Last updated: Aug 8, 2025
Ligand Pharmaceuticals Market Cap
4by4 Inc has a market cap or net worth of 166.84 billion as of August 8, 2025. Its market cap has increased by 91.36% in one year.
Market Cap
166.84B
Enterprise Value
178.34B
Revenue
30.10B
Ranking
n/a
PE Ratio
n/a
Stock Price
$14,470.00
Market Cap Chart
Since April 28, 2022, 4by4 Inc's market cap has decreased from 451.91B to 166.84B, a decrease of -63.08%. That is a compound annual growth rate of -26.20%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 7, 2025 | 166.84B | 200.55% |
Dec 30, 2024 | 55.51B | -37.83% |
Dec 28, 2023 | 89.29B | -22.54% |
Dec 29, 2022 | 115.28B | -74.49% |
Apr 28, 2022 | 451.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 460.93T |
SK hynix | 180.87T |
LG Energy Solution | 90.44T |
Samsung Biologics | 73.24T |
Hanwha Aerospace | 47.95T |
Hyundai Motor Company | 46.44T |
HD Hyundai Heavy Industries | 42.17T |
Doosan Enerbility | 41.89T |